Genetic Analysis

Dual-Responsive Nanodelivery – Review
Research & Development Dual-Responsive Nanodelivery – Review

Sophisticated nanodelivery systems that respond to multiple biological cues are rapidly redefining the landscape of targeted therapeutics, offering a highly precise method for overcoming the formidable barriers presented by diseases like metastatic cancer. This review explores the evolution of

Why Is Bladder Cancer More Deadly for the Colorblind?
Research & Development Why Is Bladder Cancer More Deadly for the Colorblind?

A faint tinge of pink swirling in the toilet bowl is an unmistakable alarm bell for most, signaling an urgent need for medical attention, but for millions, this critical warning sign of a potentially treatable cancer remains completely invisible. New research reveals a shocking reality: individuals

Will New Data Save Sarepta's Embattled Gene Therapy?
Research & Development Will New Data Save Sarepta's Embattled Gene Therapy?

With us today is Ivan Kairatov, a biopharma expert with deep experience in research and development, to discuss the evolving story of Sarepta’s gene therapy, Elevidys. We’ll explore how new long-term data is reshaping the clinical conversation around the therapy’s effectiveness, the commercial

How Does a Heart-Healthy Gene Harm the Liver?
Research & Development How Does a Heart-Healthy Gene Harm the Liver?

Today, we have the privilege of speaking with Dr. Ivan Kairatov, a leading biopharma expert whose research has illuminated the intricate connections between lipid genetics and liver health. We'll be exploring the often-overlooked condition of Familial Hypobetalipoproteinemia, or FHBL, and how this

What Is the Immune System’s Achilles’ Heel?
Research & Development What Is the Immune System’s Achilles’ Heel?

A groundbreaking collaborative study has revealed a critical vulnerability within the human immune system, uncovering a sophisticated mechanism of viral sabotage that fundamentally alters our understanding of how pathogens outsmart our natural defenses. Research has identified a single tissue

Large Study Finds No Stomach Cancer Risk From PPIs
Research & Development Large Study Finds No Stomach Cancer Risk From PPIs

For millions of people who rely on proton pump inhibitors (PPIs) to manage chronic acid reflux and other gastrointestinal conditions, a persistent concern has long cast a shadow over their treatment: the potential risk of developing stomach cancer. This decades-old question has fueled anxiety among

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later